| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/07/2012 | US20120142754 Modulation of timp1 and timp2 expression |
| 06/07/2012 | US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 06/07/2012 | US20120142696 Substituted indole/indazole-pyrimidinyl compounds |
| 06/07/2012 | US20120142679 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 06/07/2012 | US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor |
| 06/07/2012 | US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis |
| 06/07/2012 | US20120142601 Modified Peptides and Uses Thereof |
| 06/07/2012 | US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs |
| 06/07/2012 | US20120141588 Dentifrice compositions containing calcium silicate and a basic amino acid |
| 06/07/2012 | US20120141559 Bio-membrane for tissue regeneration |
| 06/07/2012 | US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 06/07/2012 | US20120141507 Targeting of glycoprotein therapeutics |
| 06/07/2012 | US20120141470 T cell inhibitory receptor compositions and uses thereof |
| 06/07/2012 | US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders |
| 06/07/2012 | US20120141449 Albumin Fusion Proteins |
| 06/07/2012 | US20120141430 Tissue Regeneration Membrane |
| 06/07/2012 | US20120141417 Collagen Preparation and Method of Isolation |
| 06/07/2012 | US20120141415 Albumin Fusion Proteins |
| 06/07/2012 | US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response |
| 06/07/2012 | US20120141391 Use of creatine or creatine compounds for skin preservation |
| 06/07/2012 | CA2819460A1 Orally disintegrating tablet |
| 06/07/2012 | CA2819399A1 Marker for determination of sensitivity to triplet combination anti-cancer agent |
| 06/06/2012 | EP2460814A1 Peptidic compound and use of same |
| 06/06/2012 | EP2460805A1 Fused imidazole derivative having ttk inhibitory action |
| 06/06/2012 | EP2460801A1 Bicyclic compound and use thereof for medical purposes |
| 06/06/2012 | EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 06/06/2012 | EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof |
| 06/06/2012 | EP2460787A1 Amide compounds and their use as PGE2 antagonists. |
| 06/06/2012 | EP2459593A2 Anti-tgf-beta receptor type ii single domain antibodies |
| 06/06/2012 | EP2459234A2 Manufacture, transport and delivery of material containing highly polarized nuclei |
| 06/06/2012 | EP2459188A1 Use of rosmarinic acid and the derivatives thereof to treat ciguatera |
| 06/06/2012 | EP1616575B1 Method for treating inflammation |
| 06/06/2012 | EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 06/06/2012 | CN1935839B Analogues of GLP-1 |
| 06/06/2012 | CN102485258A Traditional Chinese medicine composition used for treating splanchnoptosis |
| 06/06/2012 | CN102205014B Method for processing rhizoma arisaematis |
| 06/06/2012 | CN101544599B Crystal of 1,2-dihydropyridine compound |
| 06/06/2012 | CN101478960B Compounds A-R-X for the manufacture of pharmaceutical preparations |
| 06/06/2012 | CN101084924B Method for preparing goat's horn extraction |
| 06/05/2012 | US8193415 Plant expressing mammalian β1,4-galactosyltransferase and β1,3-glucuronyltransferase |
| 06/05/2012 | US8193410 Transgenic plants with controlled distribution of a trait to progeny |
| 06/05/2012 | US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 06/05/2012 | US8193249 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 06/05/2012 | US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof |
| 06/05/2012 | US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof |
| 06/05/2012 | US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 06/05/2012 | US8193217 Polymorphic form of granisetron hydrochloride and methods of making the same |
| 06/05/2012 | US8193172 Administering a steroid |
| 06/05/2012 | US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 06/05/2012 | US8192987 Human dental follicle stem cells and methods for obtaining |
| 06/05/2012 | US8192753 pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 06/05/2012 | US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 06/05/2012 | CA2557275C Bicyclo derivative |
| 06/05/2012 | CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders |
| 06/05/2012 | CA2475766C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/05/2012 | CA2435419C Halogenated composition, method for preparing same and uses thereof |
| 06/05/2012 | CA2418238C Method for treating unstable angina pectoris |
| 06/05/2012 | CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 06/05/2012 | CA2324226C Inhibitors of caspases |
| 06/05/2012 | CA2292882C Mutant having uracil phosphoribosyl transferase activity |
| 06/05/2012 | CA2249352C Immunoliposomes that optimize internalization into target cells |
| 06/05/2012 | CA2248667C Hla-a2.1 binding peptides and their uses |
| 06/05/2012 | CA2233534C Manipulation of non-terminally differentiated cells using the notch pathway |
| 05/31/2012 | WO2012070656A1 Process for production of hydroxystilbene derivative having physiological activity |
| 05/31/2012 | WO2012070649A1 Highly-soluble pyrroloquinoline quinone salt and method for producing same |
| 05/31/2012 | WO2012070601A1 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof |
| 05/31/2012 | WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism |
| 05/31/2012 | WO2012069870A1 A coumpound comprising alpha-msh for use in endodontic regeneration |
| 05/31/2012 | WO2011147926A3 Magnetically responsive membrane structures |
| 05/31/2012 | US20120136157 Aryl ureas as kinase inhibitors |
| 05/31/2012 | US20120136153 Camptothecin analogs and methods of preparation thereof |
| 05/31/2012 | US20120136004 New combination therapy in treatment of cancer and fibrotic diseases |
| 05/31/2012 | US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 05/31/2012 | US20120135982 5HT2c RECEPTOR MODULATORS |
| 05/31/2012 | US20120135929 Methods Of Modulating Uric Acid Levels |
| 05/31/2012 | US20120135376 Collagen Biomaterial Wedge |
| 05/31/2012 | US20120135086 Method of tissue repair using a composite material |
| 05/31/2012 | US20120135066 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2012 | US20120135045 Antimicrobial Collagenous Constructs |
| 05/31/2012 | US20120135008 Methods and compositions for targeting polyubiquitin |
| 05/31/2012 | US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof |
| 05/31/2012 | DE102005023301B4 Pharmazeutische Zusammensetzung enthaltend Gestagene und/oder Estrogene und 5-Methyl-(6S)-tetrahydrofolat A pharmaceutical composition comprising progestins and / or estrogens and 5-methyl- (6S) -tetrahydrofolate |
| 05/30/2012 | EP2458005A1 Fgf21 cis-element binding substance |
| 05/30/2012 | EP2457923A1 Sterol derivative |
| 05/30/2012 | EP2457920A1 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 05/30/2012 | EP2457919A1 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 05/30/2012 | EP2457589A1 Reverse targeting lipid vesicle |
| 05/30/2012 | EP2457566A1 EXTERNAL PREPARATION CONTAINING NSAIDs AND METHOD FOR PRODUCING THE EXTERNAL PREPARATION |
| 05/30/2012 | EP1702919B1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 05/30/2012 | EP1438302B1 New sulfonamide derivatives as d3-receptor ligands |
| 05/30/2012 | EP1405079B1 Modulation of the interaction between evh1 domains |
| 05/30/2012 | EP1355673B1 Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 05/30/2012 | EP1263465B1 Photodynamic cellular organism eradication using a photosensitive material and surfactant |
| 05/30/2012 | EP1214298B1 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 05/30/2012 | CN202236451U Traditional Chinese medicine soup for treating diseases of tissues of common bile and spleen channel and packaging |
| 05/30/2012 | CN1993367B Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 05/30/2012 | CN1852730B Modulators of P-selectin glycoprotein ligand 1 |
| 05/30/2012 | CN1684674B Therapeutic causing contraction of mucosal tissue, injector and therapeutic set |
| 05/30/2012 | CN1659154B Method of preparing amine stereoisomers |
| 05/30/2012 | CN102482662A 硫化氢生成酶抑制剂 Hydrogen sulfide generation inhibitors |